Citigroup
INSY

Citigroup’s Insys Therapeutics, Inc. INSY Stock Holding History

Citigroup’s Portfolio INSY Stock Details INSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-17,900
Closed -$83K – 7931
2019
Q1 		$83K Buy
17,900
+8,500
+90% +$40.2K ﹤0.01% 5929
2018
Q4 		$33K Sell
9,400
-9,700
-51% -$67.4K ﹤0.01% 6563
2018
Q3 		$193K Buy
19,100
+14,400
+306% +$115K ﹤0.01% 5298
2018
Q2 		$34K Sell
4,700
-7,500
-61% -$52.3K ﹤0.01% 6594
2018
Q1 		$74K Sell
12,200
-200
-2% -$1.65K ﹤0.01% 5878
2017
Q4 		$119K Buy
12,400
+3,700
+43% +$24.2K ﹤0.01% 5494
2017
Q3 		$77K Sell
8,700
-300
-3% -$3.1K ﹤0.01% 5756
2017
Q2 		$114K Sell
9,000
-13,400
-60% -$159K ﹤0.01% 5251
2017
Q1 		$235K Buy
22,400
+10,400
+87% +$111K ﹤0.01% 4529
2016
Q4 		$110K Sell
12,000
-7,800
-39% -$88.1K ﹤0.01% 5719
2016
Q3 		$233K Buy
19,800
+17,100
+633% +$260K ﹤0.01% 4543
2016
Q2 		$35K Sell
2,700
-15,400
-85% -$224K ﹤0.01% 5803
2016
Q1 		$289K Sell
18,100
-11,300
-38% -$215K ﹤0.01% 4737
2015
Q4 		$842K Buy
29,400
+28,500
+3,167% +$790K ﹤0.01% 3332
2015
Q3 		$26K Buy
+900
New +$33.1K ﹤0.01% 5858

Other funds holding INSY

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return

Citigroup's INSY Position: Q2 2019 in Review

Citigroup sold out of Insys Therapeutics, Inc. (INSY) in Q2 2019, closing a stake of 9,423 shares — an estimated $44K sold.

Citigroup first reported a position in INSY in Q3 2013 and held it in 23 quarters. The position peaked at $894K in Q2 2015. 16 funds tracked by Wall St. Rank hold INSY as of Q2 2019.

  • Citigroup reported no remaining Insys Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
  • Citigroup sold 9,423 Insys Therapeutics, Inc. shares in Q2 2019, an estimated $44K.
  • Citigroup first reported a position in Insys Therapeutics, Inc. in Q3 2013 and held it in 23 quarters.
  • Citigroup's Insys Therapeutics, Inc. position peaked at $894K in Q2 2015.
  • 16 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q2 2019.

Based on Citigroup's 13F filing for Q2 2019, filed 12 Aug 2019.